TREATMENT AND OUTCOME FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA
نویسندگان
چکیده
منابع مشابه
New, effective treatment using proton irradiation for unresectable hepatocellular carcinoma.
In 34 hepatocellular carcinoma patients (44 lesions), proton irradiation was performed and assessed. Proton irradiation was effective for the nodular HCCin terms of tumor size reduction and histology and almost 100%local tumor control was obtained during the observation period of at least 2 years, which is still undergoing up to 4 years. This therapy is safe and has the merit of excellent QOL d...
متن کاملSorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
Purpose. To describe the U.S. Food and Drug Administration (FDA) review and approval of sorafenib (Nexavar ; Bayer Pharmaceuticals Corp., Montville, NJ, and Onyx Pharmaceuticals Corp., Emeryville, CA), an oral kinase inhibitor, for the treatment of patients with unresectable hepatocellular carcinoma (HCC). Experimental Design. The FDA independently analyzed an international, double-blind, place...
متن کاملSorafenib for the treatment of unresectable hepatocellular carcinoma
Raf kinases and vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) tyrosine kinases are potential molecular targets for obtaining both anti-tumor cell progression and anti-angiogenesis effects in cancers, including hepatocellular carcinoma (HCC). Sorafenib is an oral multi-kinase inhibitor that mainly targets Raf kinases and receptor tyrosine...
متن کاملPreclinical studies of 166Ho-chitosan for treatment of hepatocellular carcinoma
Introduction: Recently, due to the special characteristics of 166Ho and chitosan, 166Ho-chitosan complex was developed for treatment of tumors such as hepatocellular carcinoma. This complex has been lately prepared with high radiochemical purity in our lab. The preclinical studies of the complex however should be performed to evaluate the tracer concentration in target and...
متن کاملtranscatheter arterial chemoembolization therapy for patients with unresectable hepatocellular carcinoma
conclusions we showed that in treatment of patients with unresectable hepatocellular carcinoma, tace significantly improved the disease and the overall survival rate. also, we introduce the tumor size, serum alp level, and number of liver involved segments as prognostic factors of the procedure. finally, tace can be recommended as the initial treatment for unresectable hcc patients. background ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The journal of the Japanese Practical Surgeon Society
سال: 1990
ISSN: 0386-9776
DOI: 10.3919/ringe1963.51.35